SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950103-09-000304
Filing Date
2009-02-13
Accepted
2009-02-13 16:35:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A dp12556_sc13ga2-keryx.htm SC 13G/A 46095
  Complete submission text file 0000950103-09-000304.txt   47878
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78786 | Film No.: 09604213
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1266 EAST MAIN STREET 7 FLOOR STAMFORD CT 06902
Business Address 1266 EAST MAIN STREET 7 FLOOR STAMFORD CT 06902 203-352-4000
CHILTON INVESTMENT CO LLC (Filed by) CIK: 0001332632 (see all company filings)

IRS No.: 870742367 | State of Incorp.: DE
Type: SC 13G/A